# Encompass Health Corporation  Share Price Target ‘$98.09’, now 15.7% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-share-price-target-98.09-now-15.7-upside-potential/4121164692
- Published: 2024-07-12T14:47:45+01:00
- Author: Charlotte Edwards

**Encompass Health Corporation** with ticker code (EHC) have now 11 market analysts
covering the stock. The analyst consensus now points to a rating of ‘strong_buy’.
The target price High/Low ranges between $113.00 and $95.00 with the average share
target price sitting at $98.09. (at the time of writing). Given that the stocks 
previous close was at $84.77 and the analysts are correct then we can expect a percentage
increase in value of 15.7%. The day 50 moving average is $85.10 and the 200 day 
MA is $74.28. The total market capitalization for the company now stands at 8.65B.
The stock price for the company is currently $85.90 USD

 The potential market cap would be $10,007,842,809 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 22.49, revenue per share of $49.77
and a 7.94% return on assets.

Encompass Health Corporation is a provider of post-acute healthcare service. The
Company manages its operations through its inpatient rehabilitation segment. The
Company is the owner and operator of rehabilitation hospitals. It operates hospitals
in approximately 37 states and Puerto Rico, with concentrations in the eastern half
of the United States and Texas. The Company operates approximately 156 inpatient
rehabilitation hospitals. It provides specialized rehabilitative treatment on an
inpatient basis. The Company’s inpatient rehabilitation hospitals offer specialized
rehabilitative care across an array of diagnoses and deliver comprehensive patient
care services. It also provides rehabilitative care for patients recovering from
injury or illness, using advanced technology and treatments to maximize recovery.
Its hospitals provide a comprehensive interdisciplinary clinical approach to treatment
that leverages technologies and advanced therapies and leads to superior outcomes.

Share on: